Moreover, OCs can be divided in type I (low-grade tumor with BRAF and KRAS mutations) or type II (high-grade tumor with a variety of mutations including HOX, PTEN, KRAS, AKT1, BRCA1/2 genes) [5–10] and various dysregulated mechanisms underlying the pathology [11–13]. Here, KRAS is linked to neoplasm.